Among commercially insured non-diabetic individuals with obesity, people who identified as female, received point-of-service or preferred provider organization insurance coverage, and who took medications such as antidepressants or thyroid or hormone medications, were more likely to begin taking semaglutide compared to people who identified as males, or those who were covered by health management organization or exclusive provider organization plans
Obesity: A Profoundly Under Recognized Chronic Disease, And Its Impacts on Cardiovascular Disease
Regular FedEx 3-5 days, Overnight available
467 Under hyperglycemic conditions, GLP-1RAs regulate hypertension by inhibiting carotid body function
Kumari A (2018) In: Kumari A (ed) Sweet biochemistry
Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy